Phase 2 study for people with Prostate Cancer

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Surgical Outcomes Research Centre (SOuRCe)
Registry number NCT07576335
Started 31 August 2026 Today 16 October 2026 Estimated completion 1 December 2028

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Chris O'Brien Lifehouse Sydney NSW Not yet recruiting
Royal Prince Alfred Hospital Sydney NSW Recruiting
Concord Repatriation General Hospital (CRGH) Sydney NSW Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Male participants only
Healthy volunteers Not accepted
Enrolment target 64

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

1. Adults aged ≥18 years undergoing elective robot-assisted radical prostatectomy (RARP) with curative intent for confirmed prostate cancer.

2. Consulting a urological surgeon with an appointment at participating sites at least 4 weeks prior to scheduled surgery.

3. Willingness to engage in prescribed self-directed interventions.

4. Expected to have 100% unilateral OR \>50% bilateral nerve sparing at prostatectomy

Exclusion Criteria:

1. Cognitive impairment such that they lack capacity to provide informed consent.

2. Currently taking intracavernosal injection therapy.

3. Severe or complete erectile dysfunction at baseline, defined as an IIEF-5 score ≤7 or self-reported absence of erectile function.

4. Prescribed nitrates or guanylate cyclase stimulators (e.g., riociguat) - pharmacological contraindication to PDE5 inhibitor use.

5. Impaired renal function (GFR \<50 mL/min and/or creatinine clearance \<30 mL/min).

6. Severe hepatic impairment or concurrent prescription of medications that inhibit CYP3A4.

7. Loss of vision in one eye due to non-arteritic anterior ischaemic optic neuropathy (NAION).

8. Myocardial infarction within the last 90 days.

9. Stroke within the last 6 months.

10. Unstable angina or angina occurring during sexual intercourse.

11. New York Heart Association (NYHA) Class II or greater heart failure in the last 6 months.

12. Uncontrolled arrhythmias, hypotension (\<90/50 mmHg), or uncontrolled hypertension.

13. Contraindications to participating in the prescribed exercise program.

14. No access to a device with internet connectivity.

Dates on the record

Started 31 August 2026
Estimated completion 1 December 2028
Registry last updated 9 September 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 9 September 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.